| Source: |
| Type: |
| Various antioxidants such as Nrf2, SODs, catalase, GPxs, PRDXs, and GSTs are altered in different cancers and have been linked to prognosis. Their overexpression can correlate with aggressive tumor behavior and resistance to treatment in many contexts. |
| 3346- | QC, | Regulation of the Intracellular ROS Level Is Critical for the Antiproliferative Effect of Quercetin in the Hepatocellular Carcinoma Cell Line HepG2 |
| - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Liver, | HUH7 |
| 3347- | QC, | Recent Advances in Potential Health Benefits of Quercetin |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 3343- | QC, | Quercetin, a Flavonoid with Great Pharmacological Capacity |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Arthritis, | NA |
| 3341- | QC, | Antioxidant Activities of Quercetin and Its Complexes for Medicinal Application |
| - | Review, | Var, | NA | - | Review, | Stroke, | NA |
| 3355- | QC, | Quercetin exhibits cytotoxicity in cancer cells by inducing two-ended DNA double-strand breaks |
| - | in-vitro, | Cerv, | HeLa |
| 3336- | QC, | Neuroprotective Effects of Quercetin in Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 3337- | QC, | Endoplasmic Reticulum Stress-Relieving Effect of Quercetin in Thapsigargin-Treated Hepatocytes |
| - | in-vitro, | NA, | HepG2 |
| 3338- | QC, | Quercetin: Its Antioxidant Mechanism, Antibacterial Properties and Potential Application in Prevention and Control of Toxipathy |
| - | Review, | Var, | NA | - | Review, | Stroke, | NA |
| 3361- | QC, | Quercetin ameliorates testosterone secretion disorder by inhibiting endoplasmic reticulum stress through the miR-1306-5p/HSD17B7 axis in diabetic rats |
| - | in-vivo, | Nor, | NA | - | in-vitro, | NA, | NA |
| 3366- | QC, | Quercetin Attenuates Endoplasmic Reticulum Stress and Apoptosis in TNBS-Induced Colitis by Inhibiting the Glucose Regulatory Protein 78 Activation |
| - | in-vivo, | IBD, | NA |
| 3368- | QC, | The potential anti-cancer effects of quercetin on blood, prostate and lung cancers: An update |
| - | Review, | Var, | NA |
| 3374- | QC, | Therapeutic effects of quercetin in oral cancer therapy: a systematic review of preclinical evidence focused on oxidative damage, apoptosis and anti-metastasis |
| - | Review, | Oral, | NA | - | Review, | AD, | NA |
| 6056- | RES, | SeNPs, | A comparative study of resveratrol and resveratrol-functional selenium nanoparticles: Inhibiting amyloid β aggregation and reactive oxygen species formation properties |
| - | Study, | AD, | NA |
| 3613- | RES, | Resveratrol for Alzheimer's disease |
| - | Review, | AD, | NA |
| 3858- | RES, | Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer’s Disease Treatment |
| - | Review, | AD, | NA |
| 2443- | RES, | Health Benefits and Molecular Mechanisms of Resveratrol: A Narrative Review |
| - | Review, | Var, | NA |
| 2441- | RES, | Anti-Cancer Properties of Resveratrol: A Focus on Its Impact on Mitochondrial Functions |
| - | Review, | Var, | NA |
| 2568- | RES, | Resveratrol: A Miracle Drug for Vascular Pathologies |
| - | Review, | Var, | NA |
| 2567- | RES, | Neuroprotective Effects of Resveratrol in Ischemic Brain Injury |
| - | Review, | Stroke, | NA |
| 2564- | RES, | Effect of resveratrol on platelet aggregation by fibrinogen protection |
| - | in-vitro, | NA, | NA |
| 3092- | RES, | Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action |
| - | Review, | BC, | MDA-MB-231 | - | Review, | BC, | MCF-7 |
| 3094- | RES, | Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 |
| 3099- | RES, | Resveratrol and cognitive decline: a clinician perspective |
| - | Review, | Nor, | NA | - | NA, | AD, | NA |
| 3057- | RES, | The therapeutic effect of resveratrol: Focusing on the Nrf2 signaling pathway |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Stroke, | NA |
| 3060- | RES, | Resveratrol targeting NRF2 disrupts the binding between KEAP1 and NRF2-DLG motif to ameliorate oxidative stress damage in mice pulmonary infection |
| - | in-vitro, | Nor, | RAW264.7 | - | in-vivo, | NA, | NA |
| 3062- | RES, | Resveratrol enhances post-injury muscle regeneration by regulating antioxidant and mitochondrial biogenesis |
| - | in-vivo, | Nor, | NA |
| 3063- | RES, | Resveratrol: A Review of Pre-clinical Studies for Human Cancer Prevention |
| - | Review, | Var, | NA |
| 3069- | RES, | Resveratrol Inhibits NLRP3 Inflammasome-Induced Pyroptosis and miR-155 Expression in Microglia Through Sirt1/AMPK Pathway |
| - | in-vitro, | Nor, | N9 |
| 2990- | RES, | Resveratrol reduces cerebral edema through inhibition of de novo SUR1 expression induced after focal ischemia |
| - | in-vivo, | Stroke, | NA |
| 4663- | RES, | Exploring resveratrol’s inhibitory potential on lung cancer stem cells: a scoping review of mechanistic pathways across cancer models |
| - | Review, | Var, | NA |
| 4670- | RES, | CUR, | EGCG, | TQ, | Targeting aging pathways with natural compounds: a review of curcumin, epigallocatechin gallate, thymoquinone, and resveratrol |
| - | Review, | Nor, | NA |
| 4289- | RES, | Resveratrol Attenuates Formaldehyde Induced Hyperphosphorylation of Tau Protein and Cytotoxicity in N2a Cells |
| - | in-vitro, | AD, | NA |
| 4286- | RES, | Neuroprotective Properties of Resveratrol and Its Derivatives—Influence on Potential Mechanisms Leading to the Development of Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 4284- | RES, | Resveratrol induces dephosphorylation of Tau by interfering with the MID1-PP2A complex |
| - | in-vitro, | AD, | HEK293 | - | NA, | Stroke, | NA | - | in-vivo, | AD, | NA |
| 3618- | RosA, | Antioxidant and Antimicrobial Properties of Rosemary (Rosmarinus officinalis, L.): A Review |
| - | Review, | AD, | NA |
| 3620- | RosA, | Rosmarinus officinalis and Methylphenidate Exposure Improves Cognition and Depression and Regulates Anxiety-Like Behavior in AlCl3-Induced Mouse Model of Alzheimer's Disease |
| - | in-vivo, | AD, | NA |
| 3755- | RosA, | CUR, | Development of Acetylcholinesterase (AChE) Inhibitor |
| - | Study, | AD, | NA |
| 1749- | RosA, | Rosmarinic Acid and Related Dietary Supplements: Potential Applications in the Prevention and Treatment of Cancer |
| - | Review, | Var, | NA |
| 1745- | RosA, | Rosmarinic acid and its derivatives: Current insights on anticancer potential and other biomedical applications |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 1744- | RosA, | Therapeutic Applications of Rosmarinic Acid in Cancer-Chemotherapy-Associated Resistance and Toxicity |
| - | Review, | Var, | NA |
| 1743- | RosA, | New insights into the competition between antioxidant activities and pro-oxidant risks of rosmarinic acid |
| - | Analysis, | Var, | NA |
| 3016- | RosA, | Rosmarinic Acid Inhibits Cell Growth and Migration in Head and Neck Squamous Cell Carcinoma Cell Lines by Attenuating Epidermal Growth Factor Receptor Signaling |
| - | in-vitro, | HNSCC, | UM-SCC-6 | - | in-vitro, | HNSCC, | UM-SCC-10B |
| - | in-vitro, | Lung, | A549 |
| 3018- | RosA, | Rosemary (Rosmarinus officinalis L.) polyphenols and inflammatory bowel diseases: Major phytochemicals, functional properties, and health effects |
| - | Review, | IBD, | NA |
| 3026- | RosA, | Modulatory Effect of Rosmarinic Acid on H2O2-Induced Adaptive Glycolytic Response in Dermal Fibroblasts |
| - | in-vitro, | Nor, | NA |
| 3014- | RosA, | Rosmarinic Acid Supplementation Acts as an Effective Antioxidant for Restoring the Antioxidation/Oxidation Balance in Wistar Rats with Cadmium-Induced Toxicity |
| - | in-vivo, | Nor, | NA |
| 3013- | RosA, | Rosmarinic acid inhibits angiogenesis and its mechanism of action in vitro |
| - | in-vitro, | NA, | NA |
| 3003- | RosA, | Comprehensive Insights into Biological Roles of Rosmarinic Acid: Implications in Diabetes, Cancer and Neurodegenerative Diseases |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
| 3001- | RosA, | Therapeutic Potential of Rosmarinic Acid: A Comprehensive Review |
| - | Review, | Var, | NA |
| 3028- | RosA, | Network pharmacology mechanism of Rosmarinus officinalis L.(Rosemary) to improve cell viability and reduces apoptosis in treating Alzheimer’s disease |
| - | in-vitro, | AD, | HT22 | - | in-vivo, | NA, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1103 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid